Research Spotlight: Maternal Insulin Sensitivity/Resistance During Pregnancy
The findings set the stage for novel approaches to modulate insulin resistance in pregnancy and prevent or treat gestational diabetes mellitus (GDM).
Research at Massachusetts General Hospital includes multitude of hospital-wide centers, institutes and programs as well as collaborations with other institutions.
The findings set the stage for novel approaches to modulate insulin resistance in pregnancy and prevent or treat gestational diabetes mellitus (GDM).
First patient in the U.S. with immune thrombotic thrombocytopenic purpura to receive the drug is in remission.
Hanseul Kim, PhD, is the lead author of a recently published research letter in the journal Gastroenterology, Altered Microbial Transcription in Long-Term Proton Pump Inhibitor Usage: Findings From a US Cohort Study
Researchers plan to use the results of this analysis to inform the development of a clinical decision support system to aid clinicians in the evaluation of hospitalized individuals with suspected TB.
This study was designed to investigate which cellular, transcriptional and signaling programs are associated with the development of colitis in cancer patients being treated with immune checkpoint inhibitors (ICIs).
Add description here